대한한의학회지 (The Journal of Korean Medicine)

  • 제42권2호
  • /
  • Pages.90-97
  • /
  • 2021
  • /
  • 1010-0695(pISSN)
  • /
  • 2288-3339(eISSN)
대한한의학회 (The Society of Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

중년 남성에서 접골탕 투여 후 개선된 골밀도에 관한 증례 보고

Improvement of Low Bone Mineral Density Treated with Jeopgol-tang in a Middle-Aged Man: A Case Report

  • 원지윤 (경희대학교 한의과대학 대학원 기초한의과학과) ;
  • 최영진 (경희다복한의원) ;
  • 이병철 (경희대학교 한의과대학 부속병원 신장내분비내과학교실) ;
  • 이향숙 (경희대학교 한의과대학 대학원 기초한의과학과)
  • Won, Jiyoon (Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University) ;
  • Choi, Youngjin (KyungheeDabok Korean Medicine Clinic) ;
  • Lee, Byung-Cheol (Department of Nephrology and Endocrinology, College of Korean Medicine, Kyung Hee University) ;
  • Lee, Hyangsook (Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University)
  • 투고 : 2020.12.31
  • 심사 : 2021.04.06
  • 발행 : 2021.06.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

DXA로 측정한 요추 부위와 대퇴골경의 골밀도 수치가 2년간 지속적으로 연령대 평균 이하였던 중년의 사무직 남성 환자가 접골탕을 복용하고 골밀도 수치가 개선되었다.

Bone mineral density (BMD) is a major diagnostic marker for bone health. A 44-year-old male had BMD of 0.81 g/cm2 (Z-score: -3.1) in lumbar spine scan and 0.54 g/cm2 (Z-score: -2.7) for femoral neck from regular medical checkup in Apr 2020. He had no other specific medical conditions except hyperlipidemia and alcohol was a single risk factor for fracture according to Fracture Risk Assessment Tool. After he was diagnosed with liver-kidney deficiency and treated for 20 weeks with Jeopgol-tang originally patented for promoting fracture recovery, lumbar spine BMD increased by 13.6 % (0.92 g/cm2, Z-score: -2.1) and femoral neck BMD by 22.2% (0.66 g/cm2, Z-score: -1.8) compared with those of Mar 2020. Herbal medicine treatment for tonifying liver and kidney to improve BMD warrants further investigation.

키워드

과제정보

본 증례를 발표할 수 있도록 자료의 사용을 허락해 준 환자에게 감사드린다.

참고문헌

  1. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94(6):646-50. https://doi.org/10.1016/0002-9343(93)90218-E
  2. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1-129.
  3. Mauck KF, Clarke BL. Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc. 2006;81(5):662-72. https://doi.org/10.4065/81.5.662
  4. Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B. Mortality after osteoporotic fractures. Osteoporos Int. 2004 Jan;15(1):38-42. https://doi.org/10.1007/s00198-003-1490-4
  5. Ha YC, Kim TY, Lee A, Lee YK, Kim HY, Kim JH, et al. Current trends and future projections of hip fracture in South Korea using nationwide claims data. Osteoporos Int. 2016;27(8):2603-9. https://doi.org/10.1007/s00198-016-3576-9
  6. Kim J, Lee E, Kim S, Lee TJ. Economic Burden of Osteoporotic Fracture of the Elderly in South Korea: A National Survey. Value Health Reg Issues. 2016;9:36-41. https://doi.org/10.1016/j.vhri.2015.09.007
  7. Kanis J. Assessment of osteoporosis at the primary health-care level. Technical Report: WHO Collaborating Centre, University of Sheffield; 2008 [cited Nov 2020]. Available from: http://www.shef.ac.uk/FRAX
  8. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359-81. https://doi.org/10.1007/s00198-014-2794-2
  9. Mikyas Y, Agodoa I, Yurgin N. A systematic review of osteoporosis medication adherence and osteoporosis-related fracture costs in men. Appl Health Econ Health Policy. 2014;12(3):267-77. https://doi.org/10.1007/s40258-013-0078-1
  10. Zhao JG, Zeng XT, Wang J, Liu L. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. JAMA. 2017;318(24):2466-82. https://doi.org/10.1001/jama.2017.19344
  11. Liu Y, Liu JP, Xia Y. Chinese herbal medicines for treating osteoporosis. Cochrane Database Syst Rev. 2014;(3):CD005467.
  12. Yun G, Kang J, Lee H. Effects of Korean herbal medicine (Cheong-A-Won) for treatment of bone mineral density in women with osteoporosis: A randomized, double blind, placebo controlled trial. Eur J Integr Med. 2018;20:84-9. https://doi.org/10.1016/j.eujim.2018.04.009
  13. Guide publishing group of Korean society for bone and mineral research. Physician's guide for osteoporosis. Seoul: Cdmthebig 2018.
  14. Department of kidney internal medicine. Kidney Internal Medicine. Seoul: Gunjachulpansa 2015:116-20.
  15. Lee H, Hahm D, Kim H, Sohn B, Hwang D, Choi Y, editors. The effect of Jeopgol-tang on recovery of bone fracture in Sprague-Dawley rats. The Annual Conference of Traditional Korean Medicine 2006.
  16. Lee H, Hahm D, Kim H, Sohn B, Choi Y, DS H. Crude drugs composition for accelerating recovery of bone fracture. 10-0731160. 2007.
  17. Leutner M, Matzhold C, Bellach L, Deischinger C, Harreiter J, Thurner S, et al. Diagnosis of osteoporosis in statin-treated patients is dose-dependent. Ann Rheum Dis. 2019;78(12):1706-11. https://doi.org/10.1136/annrheumdis-2019-215714
  18. Hong S, You S. A study of prevalence and related risk factors of osteoporosis for employees. JKIECS 2013;8(4):631-7.
  19. Han G, Kim S. What Cases Are Worth Publishing in the Korean Medical Case Report? Korean J Acupunct 2020;37(3):159-71. https://doi.org/10.14406/acu.2020.021
  20. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep. 2013;7:223. https://doi.org/10.1186/1752-1947-7-223
  21. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clinic proceedings. 2002;77(5):453-68. https://doi.org/10.4065/77.5.453